Kabra Drugs Ltd.
BSE: 524322 | Sector: Health care |
NSE: N.A. | ISIN Code: INE323K01017 |
BSE 00:00 | 27 Jan | 4.18 |
-0.22 (-5.00%) |
OPEN
4.50 |
HIGH
4.50 |
LOW
4.18 |
NSE 05:30 | 01 Jan | Kabra Drugs Ltd |
OPEN | 4.50 |
PREVIOUS CLOSE | 4.40 |
VOLUME | 205 |
52-Week high | 5.70 |
52-Week low | 2.95 |
P/E | |
Mkt Cap.(Rs cr) | 2 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Kabra Drugs Ltd. (KABRADRUGS) - Competition
COMPANY | Last Price | Market Cap. (Rs. cr.) |
Sales Turnover | Net Profit | Total Assets |
Sun Pharma.Inds. | 1,043.60 | 250,390.94 | 15,585.98 | -99.99 | 30,678.37 |
Divi's Lab. | 3,385.55 | 89,869.43 | 8,879.82 | 2,948.54 | 11,718.06 |
Cipla | 1,047.05 | 84,512.64 | 13,091.79 | 2,957.93 | 22,671.86 |
Dr Reddy's Labs | 4,318.30 | 71,908.33 | 14,405.20 | 1,623.20 | 20,636.20 |
Apollo Hospitals | 4,243.30 | 61,010.17 | 6,098.30 | 665.20 | 8,868.60 |
Torrent Pharma. | 1,537.80 | 52,045.30 | 6,742.32 | 991.45 | 9,910.76 |
Abbott India | 21,219.85 | 45,092.18 | 4,919.27 | 798.70 | 3,063.88 |
Max Healthcare | 455.15 | 44,187.78 | 1,800.06 | 331.13 | 6,780.23 |
Zydus Lifesci. | 430.25 | 43,549.91 | 7,981.90 | 857.90 | 16,096.50 |
Alkem Lab | 2,997.60 | 35,836.31 | 8,829.81 | 1,541.25 | 11,301.35 |
Lupin | 742.20 | 33,762.68 | 11,771.67 | -188.70 | 19,439.28 |
Biocon | 235.50 | 28,274.13 | 1,738.20 | 86.10 | 8,279.00 |
Aurobindo Pharma | 416.25 | 24,388.09 | 11,287.14 | 1,454.71 | 19,017.26 |
Syngene Intl. | 567.60 | 22,785.17 | 2,601.40 | 393.80 | 4,609.20 |
Gland Pharma | 1,357.10 | 22,351.44 | 4,400.71 | 1,212.16 | 7,164.70 |
Ipca Labs. | 850.60 | 21,579.72 | 5,399.36 | 870.94 | 6,342.72 |
Glaxosmi. Pharma | 1,261.60 | 21,372.77 | 3,217.51 | 1,690.53 | 2,948.24 |
Fortis Health. | 280.30 | 21,161.53 | 895.63 | -13.25 | 10,080.65 |
Laurus Labs | 341.85 | 18,413.75 | 4,707.04 | 750.09 | 5,178.13 |
Pfizer | 4,000.70 | 18,303.20 | 2,610.99 | 612.56 | 3,086.87 |
Quick Links for Kabra Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices